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Abstract 
Objective: To evaluate the effectiveness of a treadmill-based aerobic exercise intervention on 
pain and associated symptoms of primary dysmenorrhea. 
Methods: Seventy women with primary dysmenorrhea were included in the study. The 
experimental group underwent supervised aerobic training for 4 weeks followed by unsupervised 
home exercise for the next 6 months. The control group continued usual care. The primary 
outcome was pain. Secondary outcomes included quality of life (QoL), daily functioning, and 
sleep.  
Results: After the 4-week training, compared to the control group exercise significantly 
improved primary outcomes pain quality (mean difference (MD) -1.9, 95% CI 3.8 to -0.04, p < 
0.05), and intensity (MD -4.7, 95% CI -9.3 to -0.09, p < 0.05), but not present pain. Significant 
effects were also reported for pain interference (MD -1.7, 95% CI -3.4 to -0.02, p < 0.05) at 4 
weeks; the other outcomes did not significantly differ between groups at this time. During the 
follow-up period of 7-months, the effect on pain improved to 22 mm (95% CI 18 to 25). 
Significant benefits of exercise were maintained up to 7-months for present pain, QoL and daily 
functioning.  
Conclusion: Exercise has significant effects on primary dysmenorrhea-related pain, QoL and 
function.  
Trial registration: ACTRN12613001195741. 
Key words: Exercise; Dysmenorrhea; Pain; Quality of life; Sleep 
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Introduction          
Primary dysmenorrhea is a common gynaecological problem among women of reproductive age 
and has a high socioeconomic impact. The International Federation of Gynecology and 
Obstetrics defines primary dysmenorrhea as ‘painful cramps in the absence of any visible pelvic 
pathology that could account for it’ [1]. The prevalence of primary dysmenorrhea reported in the 
literature varies considerably, with greater prevalence among women in the age group 17 to 24 
years, and estimates ranging from 67 to 90% [2]. The pathophysiology of primary dysmenorrhea 
is primarily linked to elevated levels of prostaglandins that induce hypercontractility of the 
myometrium, leading to ischemia and hypoxia of the uterine muscle. Aerobic exercise is thought 
to reduce pain by a number of different mechanisms influencing opioid and non-opioid systems 
[3]. Aerobic exercise has been shown to influence the production of beta-endorphins which are 
mainly associated with changes in pain perception [4]. Particularly vigorous aerobic exercises 
are reported to stimulate the largest concentration of beta-endorphins [5]. These beta-endorphins 
inhibit the release of substance P, a protein crucial for the transmission of pain, and gamma 
aminobutyric acid, an inhibitory neurotransmitter that is known for inhibiting the activity of pain 
controlling structures [4,6].  
 
The effectiveness of aerobic exercise on the pain of primary dysmenorrhea is not completely 
understood. Empirical evidence about the effectiveness of aerobic exercise is needed to guide 
management of primary dysmenorrhea. Systematic reviews have confirmed the paucity of 
research in the field of aerobic exercise and primary dysmenorrhea [7,8]. To date, only two 
randomized controlled trials have evaluated the effect of aerobic exercise for primary 
dysmenorrhea.9,10 One of these studies evaluated the effects of aerobic and stretching exercise on 
pain in primary dysmenorrhea but used non-validated pain intensity outcomes [9]. The other 
study, published over thirty years ago, investigated the effects of aerobic exercise on menstrual 
distress symptoms [10]. That study reported the effects of aerobic exercise on menstrual distress 
but did not isolate effects on pain. Both studies have been rated as having low methodological 
quality in the PEDro database, with scores of 4 and 2, respectively. The lack of high-quality 
studies justifies the need for a randomized, controlled trial to investigate the effects of aerobic 
exercise for primary dysmenorrhea.  
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The research questions were: 
1. Does a 4-week aerobic exercise intervention improve pain, quality of life, daily 
functioning, and sleep in women with primary dysmenorrhea?  
2. Are any gains maintained over the following 6-month period with a home exercise 
programme?  
 
 
Methods            
Design 
This study was an assessor blinded, two arm, parallel group, randomized, controlled trial 
conducted in Dunedin, New Zealand between March 2014 and August 2015. The study protocol 
[11], based on a previously completed feasibility study [28], was prospectively registered and 
published[11]. Women with primary dysmenorrhea were randomly allocated to undertake 
regular aerobic exercise (experimental group) or usual care (control group) by a clinical research 
administrator using simple randomisation (generated using a random numbers list) with 
allocation concealment using opaque sealed envelopes. The clinical research administrator was 
an independent person with no other involvement in the study. Eligible women completed a 
screening questionnaire about demographic characteristics and details of menstrual pain and use 
of analgesics. Primary dysmenorrhea was confirmed based on information about the onset of 
primary dysmenorrhea, pain, and a history of analgesics use [11,12]. Participants then completed 
the validated short-form International Physical Activity Questionnaire [13] to determine their 
baseline physical activity levels. All participants were then provided with four sets of self-
reported outcome questionnaires and return envelopes for assessment of study outcomes at the 
first (baseline, week 0) and second menstrual periods (post-intervention, week 4), and menstrual 
periods at the end of 4 and 7 months. The principal investigator was blinded to group allocation 
during data analysis, with the two groups being assigned a code which was revealed only after 
the analysis was completed. A research assistant double-entered raw data onto an electronic 
spreadsheet and prompted return of questionnaires.  
 
Participants, therapists, centres 
Potential participants were recruited through public and university campus advertising. 
Eligibility criteria for this study were based on the guidelines for diagnosing primary 
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dysmenorrhea from the Society of Obstetrics and Gynecologists of Canada [14] and in 
accordance with the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials 
(IMMPACT) recommendations for clinical trials that evaluate the effect of interventions on pain 
[15]. The study included women with primary dysmenorrhea who: were in the age group 18 to 
43 years; were not pregnant; were having regular menstrual cycles; and reported moderate-to-
severe primary dysmenorrhea-associated pain, indicated by a score of ≥4 on a numerical rating 
scale ranging from ‘no pain’ (0) to ‘unbearable pain’ (10) for at least two previous consecutive 
menstrual periods [16,17]. The exclusion criteria applied during recruitment, including rationale 
for use are presented in Table 1. Baseline assessments of outcomes were completed during the 
first menstrual period following entry into the study. A detailed description of the outcomes was 
published [11] and is described further, below. The principal investigator – a registered 
physiotherapist with 3 years of specialist experience in the area of pain and women’s health – 
provided the exercise intervention at the University of Otago’s School of Physiotherapy. 
 
Intervention 
The clinical research administrator, upon receiving the completed baseline questionnaire, 
informed the experimental group participants of their group allocation by phone, and made 
appointments for the exercise intervention. The training period started on the day following the 
last day of menstruation of the first menstrual period, and ended before the start of the second 
menstrual period. Exercise intervention was provided as outlined in the protocol.11 Participants 
were screened for exercise safety using the Physical Activity Readiness Questionnaire before 
starting the exercise programme to determine safety or possible risk of exercising. The exercise 
intervention was for 7 months. Participants underwent supervised aerobic training on a treadmill2 
for four weeks at the school, which was followed by an unsupervised, maintenance programme 
at home for 6 months. Treadmill training was preceded by warm-up exercises for 10 minutes and 
followed by cool down exercises for 10 minutes, including stretching for mid and lower back, 
stretches for the pelvic region and strengthening of abdominal and gluteal muscles. Participants 
performed exercise between menstrual periods, with no exercises during the week of 
menstruation. The aerobic training at the School of Physiotherapy was performed 3 times per 
week at 70 to 85% of their maximum heart rate, calculated as 206 minus 88% of age (in years) 
                                                 
2 Weslo Cadence 920, ICON Fitness Lifestyle Limited, Leeds, UK 
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[18]. The conventional age-predicted formula (ie, 220 – age) was not used because it is not 
gender specific, and has also been criticised for overestimation of the maximum heart rate among 
young women and underestimation among older women [18]. During the sessions, participants 
recorded the distance covered on the treadmill via a pedometer3  and their heart rate via a 
monitor4 worn on the wrist. Owing to funding limitations, participants were not provided with 
pedometers for the unsupervised maintenance programme at home. The exercises and aerobic 
training were taught and supervised on a one-to-one basis at the School of Physiotherapy. 
 
The Borg Rating of Perceived Exertion (RPE) Scale from 6 (‘no exertion at all’) to 20 (‘maximal 
exertion’) was used to regulate the exercise intensity on the treadmill. Participants were 
encouraged to increase the speed of the treadmill until they perceived their RPE to be between 14 
and 16. Some study participants had access to a treadmill at the university gym. Other 
participants who did not have access to a treadmill were encouraged to continue with outdoor 
walking or jogging. Participants were provided with an adherence diary with the average 
distance covered on the treadmill at the School of Physiotherapy and were requested to adhere to 
the target intensity (RPE 14 to 16) and distance of aerobic training. Exercise group participants 
were requested to record the frequency (number of days per week) and duration of home exercise 
in the adherence diary. For ethical reasons, no restrictions were placed on the use or amount of 
analgesics by the exercise group participants. 
 
Control group participants were informed of their group allocation by phone and requested to 
continue to manage their pain as usual, e.g. with analgesics. Women in the control group did not 
receive trial intervention but completed the study measures. As with the experimental group 
participants, no restrictions were placed on the use or amount of analgesics and activity 
undertaken by the control group participants. Monthly phone calls were made to control group 
participants to enquire about their pain and to remind them to complete the questionnaires.  
 
Outcome measures 
                                                 
3 Digi-Walker SW-700/701, Yamax Health & Sports Incorporated, San 
 
4 Polar FSI Fitness, Polar Electro Inc, New York, USA 
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Assessments were done at baseline (Month 0), at the end of intervention period at the school (4 
weeks), and Months 4 and 7.  
Primary outcome 
Pain was measured using the validated short-form McGill Pain Questionnaire [19]. The three 
sub-scales of this questionnaire are: pain quality, measured with the Pain Rating Index; pain 
intensity, measured with the 0–100 mm Visual Analogue Scale; and the ‘present pain’ measured 
with Present Pain Index [20]. A higher score on any sub-scales of the questionnaire indicates 
worse pain [20]. Participants were instructed to complete all three sub-scales of the questionnaire 
on the day of maximum pain of menstruation, rating their current pain. 
 
Secondary outcomes 
Quality of life was measured using the validated 12-Item Short-form Health Survey (SF-12) [21]. 
The SF-12 yields two different summary scores: the Physical Component Summary for physical 
health and the Mental Component Summary for mental health [22]. A higher score on the SF-12 
indicates better health [22]. The impact of pain on daily functioning was measured using the 
Brief Pain Inventory-short form [23]. This questionnaire includes four pain severity items, seven 
interference items (general activity, mood, walking ability, normal work, relation with other 
people, sleep, and enjoyment of life) rated on a scale from 0 to 10, and the percentage pain relief 
obtained from analgesics in the past 24 hours [11]. Participants were also required to record the 
name of the analgesic consumed for pain but dose or consumption was not recorded. A lower 
score on the questionnaire represents lower severity and less interference [23]. Sleep quality was 
measured using the Women’s Health Initiative Insomnia Rating Scale (WHIIRS) [24]. A score of 
9 or greater out of 20 on the WHIIRS indicates clinical insomnia [24,25]. Higher scores on 
WHIIRS indicate more severe insomnia symptoms [24]. The participants’ perception of global 
improvement was measured using the Patient Global Impression of Change (PGIC) scale [26]. 
Because the PGIC measures improvement or deterioration, it was not completed at baseline. 
Based on a previous study, a rating of 6 (‘much improved’) or 7 (‘very much improved) on the 
PGIC was nominated a priori as the smallest worthwhile effect [27]. Adherence to exercise 
sessions at the School of Physiotherapy was assessed through session attendance. An exercise 
adherence diary was used to record adherence to the unsupervised maintenance programme. An 
acceptable level of adherence of 80% was established a priori [9].  
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Data analysis 
A power calculation was performed for the study, based on the 0–100 mm pain VAS outcome. 
The anticipated standard deviation was 18.14 mm, based on data from the feasibility study [28]. 
A between-group difference of 15 mm for pain on the VAS was nominated as the smallest 
worthwhile effect [29]. The required sample size was estimated to be 70 (35 in each group, 
assuming 90% power, a two-tailed 0.05 level of significance, and allowing for 15% dropouts. 
Statistical analysis was performed using SPSS version 22.0 (Armonk, NY) with an intention-to-
treat approach. Statistical significance was established as p < 0.05. Missing data were replaced 
with group means. A sensitivity analysis using a ‘last observation carried forward’ approach was 
carried out for VAS. Weekly physical activity levels were based on the average metabolic 
equivalent tasks [13]. Statistical analysis followed a pre-specified protocol [11]. Statistical 
analyses was done using repeated-measures analysis of covariance (ANCOVA) with baseline 
score as the covariate for all primary and secondary outcomes except PGIC. For PGIC, numbers 
and percentages were calculated and compared across groups. Bonferroni correction was done 
for significant group-by-time interaction effects [30].  
 
Results             
Figure 1 summarises the flow of participants flow through the study. Seventy-nine women were 
screened for inclusion in the study. Seventy women meeting the eligibility criteria were 
randomized to the experimental group (n = 35) and the control group (n = 35). Two, five, and 
seven participants were lost to follow-up in the control group at 1, 4 and 7 months respectively. 
Three, two, and eight participants were lost to follow-up in the intervention group at 1, 4 and 7 
months respectively. Following the intention-to-treat protocol, final analysis was done for 35 
participants in each group. The participants’ baseline physical activity levels and pain for the two 
preceding menstrual cycles are presented in Table 2. The baseline values of the primary and 
secondary outcome measures are presented in Supplementary Table 1. No adverse events were 
reported. With regard to the unsupervised exercise sessions, participants performed exercises on 
an individual basis. 
  
Effects of intervention 
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Table 3 shows the calculated between-group differences at one, four and seven months. 
 
Primary outcome 
Exercise provided statistically significant benefits at 1-month for pain quality (Pain Rating 
Index) and pain intensity (both p < 0.05) compared with the controls. These benefits were 
maintained at 4 and 7 months (all p < 0.01). The benefits at 7 months for pain intensity were also 
clinically worthwhile, with a mean benefit of a 21-mm reduction in pain intensity on the 100-mm 
VAS. A sensitivity analysis using the ‘last observation carried forward’ approach did not alter 
the results obtained on the VAS at 7 months (p < 0.01).  
 
For the Present Pain Index, no significant effect was observed at 1 month (p > 0.05). Statistically 
significant benefits from exercise were observed at 4 and 7 months (both p < 0.01); however, the 
mean estimates and even the upper limits of the confidence intervals did not reach 1 point on the 
5-point scale, suggesting that they may not be clinically worthwhile effects on their own.   
 
Secondary outcomes 
On the SF-12 quality of life questionnaire, the Physical Component Summary and the Mental 
Component Summary did not show a significant effect at 1 month (p > 0.05). Statistically 
significant benefits were observed at 4 and 7 months (all p < 0.01). Similarly, on the Brief Pain 
Inventory-short form the pain severity data showed no significant effect at 1 month, but 
statistically significant benefits were observed at 4 and 7 months (all p < 0.01). Again, however, 
the mean estimates were less than 4 points on the 40-point scale, so they may not be clinically 
worthwhile on their own. The pain interference data showed statistically significant benefits of 
exercise at 1 and 4 months (p < 0.05) and at 7 months (p < 0.01), while the data about percentage 
pain relief with analgesics showed statistically significant benefits at 4 and 7 months (p < 0.01). 
Again these effects did not exceed 10% of the scales on which they were measured. For the 
secondary outcome of sleep, there was no significant effect of exercise at months 1, 4 or 7.  
 
For the scores of PGIC, based on the planned analysis of the absolute number of participants 
with a clinically significant change score, no significant effect of exercise was observed at 1 
month (p > 0.05). However, significantly more participants rated their global change as ‘much 
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improved’ or ‘very much improved’ in the experimental group compared with the control group 
at 4 months (p < 0.05) and 7 months (p < 0.01). 
 
 
 
Discussion           
This is the first randomized controlled trial to evaluate the effects of a treadmill-based exercise 
intervention on multiple domains affected by primary dysmenorrhea. The trial was able to 
demonstrate that exercise was significantly more effective than control in reducing pain quality, 
intensity, and interference at 4 weeks. By continuing the follow-up of participants for 6 more 
months, the trial was also able to demonstrate that this beneficial effect of exercise on pain was 
sustained to 4 and 7 months. In addition, from 4 months to the completion of the study, there 
were significant and sustained benefits of the exercise in quality of life, daily functioning, and 
PGIC. No beneficial effects of exercise were identified on sleep at any of the assessment time 
points. 
 
This, study not only demonstrated statistically significant improvements in primary 
dysmenorrhea-associated pain with increasing benefit over a 6-month follow-up period, but 
additionally the best single estimate of the effect of exercise on the primary outcome for pain 
(VAS) surpassed the threshold for clinical significance (20mm) [31]. The improvements 
observed in quality of life scores due to exercise at 7 months are noteworthy. There was a mean 
change of 4.8 points in the Mental Component Summary score of the SF-12 (Supplementary 
Table 1). A 5-point increase in the Physical Component Summary or Mental Component 
Summary of the SF-12 has been reported as predictive of satisfaction with intervention in women 
with non-cancerous pelvic pain [32].  
 
Another important consideration in interpreting the results is that there were statistically 
significant and sustained benefits across many of the secondary outcome measures. These 
multiple benefits (ie, improved quality of life, less interference from pain in daily functioning, 
etc) could be considered as a ‘package deal’ by patients. Therefore, although many of these 
benefits may not be clinically worthwhile, sustained benefits together with the substantial and 
12 
 
sustained effect on the primary outcome, use of exercise to help ameliorate pain and its sequelae 
may be appealing to many patients with primary dysmenorrhea.  
 
One of the anticipated benefits of exercise for participants was improved sleep quality. Moderate 
to vigorous intensity aerobic exercises are generally thought to improve sleep [33]; However, this 
study found no improvements in sleep with the intervention. This lack of improvement in sleep 
could be due to the inclusion of participants with no sleep difficulties. The mean baseline score 
(3.2) of the experimental group participants (Supplementary Table 1) was less than the clinical 
insomnia score of 9 out of 20 for the WHIIRS [22], indicating those participants began the 
intervention with no insomnia symptoms. It is therefore recommended that minimum levels of 
sleep loss could be set as inclusion criteria for future primary dysmenorrhea trials attempting to 
measure sleep as an outcome.  
 
Several pain relieving mechanisms, including non-opioid and opioid systems have been proposed 
for exercise-induced changes in pain sensitivity [3,34,35], and may explain the reductions in pain 
demonstrated in this study. Firstly, exercise is thought to induce release of endogenous opioids 
(beta-endorphins) at central, spinal and/or peripheral levels all of which contribute to pain 
modulation.3,35 Secondly, the endocannabinoid-mediated mechanism is thought to contribute to 
exercise-induced analgesia.3 Endocannabinoids are receptors that contribute to the control of 
pain transmission within the brain and spinal cord [3]. Elevations in peripheral blood 
endocannabinoids concentrations have been reported following aerobic exercise, and it is has 
been suggested that the activation of cannabinoid receptors produces analgesia [3]. Finally, 
exercise also induces the release of regulatory macrophages in the physically active muscles 
[35]. These regulatory macrophages are known for their ability to secrete anti-inflammatory 
cytokines and counteract the effect of other activated macrophages which secrete pro-
inflammatory cytokines [35]. Therefore, following physical activity the overall effect is an 
increase in anti-inflammatory cytokines which are responsible for pain reduction [34,35]. The 
intervention tested in this study has the capacity to induce any or all of these mechanisms. 
 
The exercise intervention was employed in this study when women were not menstruating. 
Changes in hormone levels during different phases of the menstrual cycle are thought to be 
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associated with decreased exercise performance and increased laxity in ligaments, particularly 
the anterior cruciate ligament (ACL) of the knee [36,37]. A study of ACL laxity related to the 
menstrual cycle confirmed the risk of ACL injury in the menstruation phase [38]. Despite ACL 
injuries being common in pivoting sports [39] and least common in sports without cutting or 
pivoting movements such as running, we restricted women from exercising during menstruation 
considering the impact of menstrual cycle on exercise performance and consistent with previous 
studies of aerobic exercise for primary dysmenorrhea [9,10]. Future studies are recommended 
and required for investigating the anecdotal belief that exercising during menstruation might 
decrease menstrual bleeding and discomforts of menstruation.  
 
The main strengths of this study are that the methodology was robust, and the feasibility of 
providing the intervention was tested. There was also a good representation of participants in all 
the target age ranges, as well as an equal percentage of participants recruited from non-university 
settings in both groups (40%). Therefore, the findings of this study can be generalised across the 
age range of women with primary dysmenorrhea. We considered using exercise diaries or logs to 
evaluate compliance with the home exercise programme. However, the limitation of such 
methods has been reported in previous studies [40,41] and we therefore elected not to include 
these in our study. Lack of monitoring of the home exercise programme could be considered a 
limitation of the study. Another issue with using self-reported measures is that participants may 
over report their activity levels. In which case the results could be even greater if all prescribed 
exercise sessions were to be completed as intended. Another limitation may be that, although 
participants in the exercise and control groups were permitted to take analgesics to manage their 
pain, the amount or number of analgesics consumed was not monitored or recorded.  It is 
therefore difficult to confirm if the amount of analgesics consumed was consistent between the 
groups. This is considered a potential limitation of the study because the amount of analgesics 
consumed may have influenced the treatment effects reported for percentage pain relief with 
analgesics in this study. Another limitation of our study is that, participants and the principal 
investigator were not blinded to treatment groups. However, outcomes assessments were all self-
reported and analysis was done blinded. Lastly, there were a number of participants who were 
lost to follow-up at 7 months in both the groups. The present study was powered to allow 15% 
dropouts however, the dropout rate was 21% at 7 months follow-up. Thus, the study would not 
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be adequately powered according to per-protocol analysis. However, it is acknowledged that the 
study was adequately powered with intention-to-treat analysis. That is, whether the last 
observation was carried forwards (assuming there was no change from the last measurement 
point) or the mean of the group was imputed as missing data the effects of exercise were highly 
significant for most outcomes at 7-months. This provides a strong argument supporting the 
effects of exercise. Reasons for dropping out of study is not known, it is unlikely that it could be 
related to intervention parameters because our feasibility study identified good acceptance 
towards the intervention and intensity of training. We recommend future studies to conduct focus 
groups to obtain participants feedback about the intervention and monitor and record the name 
and number/amount of analgesics consumed. 
 
The evidence supporting the use of aerobic exercise for managing pain, improving quality of life 
and improving daily functioning has been strengthened by the findings from this research. 
However, it is difficult to draw any definitive conclusion from a single randomized trial. Owing 
to the many benefits of aerobic exercise identified in this study, aerobic exercise could be 
considered a useful treatment option for the management of primary dysmenorrhea. This study 
found no evidence to support the use of aerobic exercise for improving sleep in women with 
primary dysmenorrhea.  
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Table 1. Exclusion criteria and justification for use of each criterion.  
 
Exclusion criteria Justification for use of the criterion 
Pregnant women Pregnant women will not have periods to assess. 
Women with irregular 
menstrual cycles 
Irregular cycles are indicative of secondary dysmenorrhea [42].  
Menstrual cycles >35 days 
apart 
Prolonged gaps between menstrual cycles are suggestive of anovulatory 
cycles and oligomenorrhea [43,44]. Oligomenorrhea is associated with a 
pathology either in the reproductive system or brain (pituitary tumours) [45]. 
Women on OCP, hormonal 
therapy and women using 
intrauterine devices 
These interventions are thought to affect ovulation and/or menstruation [46]. 
No pain relief with over the 
counter analgesics 
No response to analgesics is suggestive of secondary dysmenorrhea [12].  
OCP = oral contraceptive pills. 
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Table 2. Baseline measurements of physical activity levels, and mean pain 
 
Outcomes Exp 
(n = 35) 
Con 
(n = 35) 
Physical activity level, n (%)   
   low 23 (66) 21 (60) 
   moderate 10 (29) 13 (37) 
   high 2 (6) 1 (3) 
Past period pain (0 to 10), mean (SD) a   
   Period 1 6.5 (1.3) 6.5 (1.3) 
   Period 2  6.8 (1.3) 6.6 (1.0) 
Con = control group, Exp = experimental group, NRS = Numerical Rating Scale.  
a Period 1 and 2 represent the participant-reported pain intensity of two consecutive menstrual periods and were 
used to assess eligibility for study participation. 
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Table 3. Mean (95% CI) of difference between groups at all time points. 
 
 
Outcomes  Mean difference between groups 
 Month 1 
 
Month 4 Month 7 
Primary outcome    
PRI -1.9 (-3.8 to -0.04) -2.1 (-3.3 to -0.89) -2.4 (-3.6 to -1.1) 
VAS -4.7 (-9.3 to -0.09) -18.9 (-22.7 to -15.2) -21.1 (-24.8 to -17.5) 
PPI -0.11 (-0.42 to 0.20) -0.44 (-0.72 to -0.16) -0.49 (-0.80 to -0.18) 
Secondary outcomes    
PCS 2.0 (0.00 to 4.2) 4.0 (1.6 to 6.4) 4.8 (2.2 to 7.6) 
MCS 1.3 (-0.42 to 3.1) 2.8 (1.0 to 4.7) 4.5 (2.4 to 6.6) 
Pain severity  -0.40 (-0.80 to 1.2) -2.3 (-3.9 to -0.78) -3.1 (-4.6 to -1.6) 
Pain interference -1.7 ( -3.4 to -0.02) -2.0 (-3.6 to -0.43) -2.2 (-3.7 to -0.81) 
% pain relief 1.7 (-0.61 to 4.2) 5.1 (2.0 to 8.3) 6.3 (3.2 to 9.3) 
Sleep 0.49 (-0.99 to 0.00) 0.49 (-1.0 to 0.02) 0.46 (-0.94 to 0.00) 
Abbreviations Con: Control group; Exp: Experimental group; MCS: Mental Component Summary; PCS: Physical 
Component Summary; PPI: Present Pain Index; PRI: Pain Rating Index; QoL: Quality of Life; VAS: Visual Analogue 
Scale 
For pain and daily functioning, negative values favour the experimental group; for all other outcomes negative values 
favors the usual care group. Pain was measured using the short-form McGill Pain Questionnaire (SF-MPQ). Quality 
of life was assessed using the 12-Item Short-form Health Survey (SF-12). The impact of pain on daily functioning was 
assessed using the Brief Pain Inventory-short form (BPI-sf) 
 
 
 
 
